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Streptococcus iniae causes severe septicemia and meningitis in farmed fish and is also occasionally zoonotic. Vaccination against
S. iniae is problematic, with frequent breakdown of protection in vaccinated fish. The major protective antigens in S. iniae are
the polysaccharides of the capsule, which are essential for virulence. Capsular biosynthesis is driven and regulated by a 21-kb
operon comprising up to 20 genes. In a long-term study, we have sequenced the capsular operon of strains that have been used in
autogenous vaccines across Australia and compared it with the capsular operon sequences of strains subsequently isolated from
infected vaccinated fish. Intriguingly, strains isolated from vaccinated fish that subsequently become infected have coding muta-
tions that are confined to a limited number of genes in the cps operon, with the remainder of the genes in the operon remaining
stable. Mutations in strains in diseased vaccinated fish occur in key genes in the capsular operon that are associated with polysac-
charide configuration (cpsG) and with regulation of biosynthesis (cpsD and cpsE). This, along with high ratios of nonsynony-
mous to synonymous mutations within the cps genes, suggests that immune response directed predominantly against capsular
polysaccharide may be driving evolution in a very specific set of genes in the operon. From these data, it may be possible to de-
sign a simple polyvalent vaccine with a greater operational life span than the current monovalent killed bacterins.
Evasion of the adaptive immune response through genetic evo-lution of a pathogen is a major factor governing long-term
vaccine success (15). This is dependent on the nature of the anti-
gens targeted by the adaptive immune response: if they are highly
conserved, the diversity among the population will be low, or the
population may be eliminated altogether, with reemergence of
disease in vaccinated stock rarely occurring (15, 16). In contrast,
adaptive immune selection against highly polymorphic antigenic
determinants may result in pathogen populations restructuring
into antigenic types or serotypes, with certain types predominat-
ing in vaccinated stock and fluctuations in the genetic structure of
the population dictated by the serotype or types included in the
vaccine (15).
Vaccinations against Streptococcus iniae infections in barra-
mundi farms in Australia provide an ideal model for exploring
evolution of pathogen populations. First, it is almost impossible to
eliminate the source of infection from the farm. In ponds and
marine cage systems, reinfection from sediments, wild fish, and
other aquatic inhabitants is unavoidable (1, 7, 8). Even in com-
pletely enclosed recirculating systems, economics dictate that the
system cannot be shut down and disinfected completely; thus,
populations of the pathogen are likely to remain in biofilms on the
pipework, tanks, and filters. Second, the infectious agent S. iniae is
highly variable (6, 12, 26), with its major antigenic determinant,
polysaccharide capsule (6, 18, 21), being highly polymorphic:
novel capsular serotypes have already led to vaccine failure in fish
farms in several parts of the world, including Australia (1, 4, 11,
26). Finally, in Australia, there is no licensed generic vaccine
against S. iniae, so autogenous vaccines (“custom” vaccines pre-
pared from an isolate taken directly from the original farm and
used only on that farm) are routinely employed to prevent strep-
tococcosis. This creates a closed cycle whereby a pathogenic strain
isolated from a particular farm is used to prepare a vaccine that is
then used to vaccinate stocks that are reintroduced onto the same
farm.
The capsular polysaccharide (CPS) is located on the outermost
layer of bacterial cells and is ubiquitous across several bacterial
species (28). For pathogenic Streptococcus species, CPS varies de-
pending on serotype and is a recognized virulence factor that con-
tributes to immune evasion (10, 18). In group B Streptococcus
(Streptococcus agalactiae), variations in the polysaccharide capsule
have been implicated in reduced complement C3b binding and,
ultimately, avoidance of phagocytosis (19). Similarly, research on
Streptococcus pneumoniae revealed thatmorphological changes in the
capsule occur in order to adapt to the host’s environment (13). In
Streptococcus iniae, as with the other streptococcal species, produc-
tion of the capsular polysaccharide appears to be necessary for infec-
tion (21). Locke and colleagues (17) elegantly demonstrated that
cpsD, a homologue of a gene shown to be required for CPS produc-
tion in group B Streptococcus and S. pneumoniae, was required for
capsule formation and export in S. iniae. Although a few studies have
investigated virulence factors in S. iniae, the function of the genes in
the capsular operon are less well known, and how these translate into
multiple serotypes in this species is yet to be elucidated.
In the present study, we investigated molecular evolution of
the capsular operon of S. iniae from diverse origins in order to
determine which genes were most variable. We found that five
genes out of the approximately 21-kb cps operon were highly vari-
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able, and when we investigated case studies of repeated autoge-
nous vaccination and vaccine failure at Australian barramundi
farms for links between the highly mutable genes and reinfection
of vaccinated stock, we found a direct correlationwith the variable
cps genes and vaccination failure. Surprisingly, no capsule was
formed in some of our isolates, yet the pathogen was still able to
infect the host, albeit with a completely different pathology. To
further understand these findings on the effect of vaccination
against S. iniae, we examined serological cross-reactivity using
antibodies raised in fish between isolates with differing cps gene
sequences from several of the case studies in which vaccinated
stock became reinfected. Our results suggest that polyvalent vac-
cines comprising different cps sequence types are partially effective
but that future generic vaccines may need to target alternative
antigens that are less polymorphic than CPS.
MATERIALS AND METHODS
Bacterial strains and culturing. Bacterial isolates received from culture
collections or direct fromfish farms or veterinarianswere stored at80°C
in Todd-Hewitt broth (THB) containing 20% glycerol until required and
are listed in Table S1 in the supplemental material. Strains were recovered
from stockwithout defrosting and grown onColumbia agar base contain-
ing 5% defibrinated sheep blood (Oxoid, Australia) at 28°C for 24 to 48 h.
Where isolates were obtained from farm cases through veterinarians, his-
topathology was performed by the veterinary laboratories using standard
techniques. Identity of strains was confirmed by diagnostic PCR as previ-
ously described (20, 27) and by sequencing the 16S rRNA gene (26, 27).
DNAextraction, primer design, PCR, and sequencing. S. iniae genomic
DNAwas extracted from freshly grown cells using an enzymatic lysismethod
aspreviouslydescribed (27a).Primers forPCRandsequencingweredesigned
using the S. iniae capsule operon sequence available on GenBank (sequence
accession number AY904444). The primers used were as described in Barnes
(5) and are listed in Tables S2 and S3 in the supplemental material.
Capsular operon genes were amplified individually or in blocks of
several genes (see Table S2 in the supplemental material) with a proof-
reading DNA polymerase (PrimeStar HS DNA polymerase; TaKaRa, Ja-
pan) in 25-l reactions composed of 5l of 5 PCR buffer, 0.5l of each
deoxynucleoside triphosphate (dNTP) (2.5 mM), 100 ng of each primer,
0.15l of PrimeStarDNAHSDNApolymerase, 100 to 200 ng of extracted
bacterial DNA, and the balance made up of sterile Milli-Q water. Reac-
tions were carried out at annealing temperatures appropriate to each
primer pair (see Table S2 in the supplemental material) (5). A “hot start”
technique was employed to reduce the likelihood of nonspecific amplifi-
cation products prior to cycling as follows: 2 min at 94°C for one cycle,
followed by 35 cycles of denaturation for 15 s at 94°C, 30 s at an appro-
priate annealing temperature, and extension at 72°C of 1 min for every
expected kb of the amplicon. Reactionmixtures were analyzed by agarose
gel electrophoresis.
Where a single ampliconwas produced, 0.6l of PCRproductwas added
to 0.3 l of a 1:2 mixture of exonuclease I and shrimp alkaline phosphatase
and 3.1l of sterileMilli-Qwater and incubated at 37°C for 30min, followed
by heating at 85°C for 15 min before being sent for DNA sequencing by the
Australian Genome Research Facility (AGRF; Brisbane, Australia). Where
more thanoneampliconwasobserved (rarely), theywere excised fromthegel
with a sterile scalpel blade and then extracted from the gel slice using a com-
mercial gel purification kit for subsequent sequencing (MEGA-Spin gel ex-
traction kit; Intron Biotechnology, South Korea).
Chromatograms were analyzed using Sequencher v. 4.9 (Genecodes).
Contigs were assembled using equivalent genes from the published ge-
nome as references, and the assembled complete cDNA sequences were
compared to the reference sequences using both nucleotide and translated
variance tables in Sequencher 4.9. Sequence types (STs) were assigned on
an ad hoc basis as discovered, with the sequence types for the type strain
assigned ST1.Changes resulting in an amino acid changewere assigned ST
numbers, while synonymous nucleotide changes were denoted with a let-
ter appended to the identical amino acid sequence type. Sequences for
each of the STs of cps genes were uploaded to GenBank as follows: cpsY
ST1 and ST2, GenBank accession numbers JX164243 and JX164242, re-
spectively; cpsD ST1, ST2, ST3, ST3A, and ST4, GenBank accession num-
bers JX164238, JX164245, JX164246, JX164239, and JX164247, respec-
tively; cpsE ST1, ST2, ST3, ST4, ST5A, ST5, ST6, ST7, and ST8, GenBank
accession numbers JX164231, JX164248, JX164232, JX164233, JX164249,
JX164234, JX164235, JX164236, JX164237, and JX164250, respectively;
cpsG ST1, ST2, and ST3,GenBank accession numbers JX164240, JX14244,
and JX164241, respectively; and cpsH ST1, GenBank accession number
JX181784.
Buoyant density assays. As an estimate of quantity of CPS expressed
by differing strains, buoyant density was determined in continuous Per-
coll gradients as described previously (17). Briefly, a standard isotonic
Percoll solution was prepared by mixing 9 parts Percoll with 1 part 1.5 M
NaCl. Mid-exponential-phase and stationary-phase THB cultures of each
strain were washed in phosphate-buffered saline (PBS) and resuspended
to an optical density at 600 nm (OD600) of2.5, and a 0.5-ml aliquot was
layered onto the Percoll. All gradients were centrifuged simultaneously in
an Eppendorf 5518E refrigerated centrifuge at 4,000 g for 90 min with
no brake. The experiment was repeated using new cultures at least twice.
Serological cross-reactivity by a whole-cell enzyme-linked immu-
nosorbent assay (ELISA). Lates calcarifer barramundi weighing 35 g were
obtained from a commercial farm and held in 300-liter round plastic tanks
with aerated brackish (5-ppt) water at 30  1°C that were connected to a
recirculating system.Water quality was maintained with mechanical and bi-
ologicalfiltrationandcheckeddaily, andwater changeswere conductedwhen
required. The fish were acclimated for 7 days and were fed to satiation with a
commercial pelleted diet (Ridley Aqua Feeds, Narangba, Australia).
Fish were anesthetized with Aqui-S (Aqui-S, Lower Hutt, New Zea-
land) in accordance with the manufacturer’s instructions and then vacci-
nated by intraperitoneal (i.p.) injection with 100l of oil-adjuvanted (1:1
emulsion in Freund’s incomplete adjuvant) formalin-killed bacterin.
Control fish were injected i.p. with PBS/adjuvant emulsion. Fish were
allowed to recover in clean aquariumwater before being returned to their
respective tanks.
A total of 900 degree days postvaccination (i.e., 30 days at 30°C), the
fish were euthanized by lethal overdose of anesthetic (Aqui-S) and bled by
caudal venipuncture. Blood samples were allowed to clot at 4°C overnight
andwere centrifuged at 6,000 g for 15min to collect serum thatwas then
stored at20°C for subsequent analysis.
The specific antibody response of each individual vaccinated fish was
determined using an enzyme-linked immunosorbent assay (ELISA) as
described previously (9) with modifications. Microlon flat-bottom 96-
well ELISA plates (Greiner) were coated by evaporating 100 l/well of
formalin-inactivated suspension (OD600  1.0) of QMA0177 and
QMA0191 in coating buffer (carbonate-bicarbonate buffer [Sigma, Aus-
tralia]) with a hair dryer. Coated plates were washed 3 times with Tris-
buffered saline containing 0.1% Tween 20 (TBST) and blocked with 2%
normal goat serum in TBST at room temperature for 1 h. The plates were
washed 3 times with TBST, and 100 l primary antisera from vaccinated
fish and control serum from sham-vaccinated siblings was diluted 1:4 in
TBST and incubated for 2 h at room temperature. Wells were washed 3
times with TBST, and secondary antibody (monoclonal mouse anti-bar-
ramundi IgM, diluted 1:32-fold in TBST [Aquatic Diagnostics, Stirling,
United Kingdom]) was added and incubated for 1 h at room temperature.
Wells were washed three times with TBST before addition of tertiary an-
tibody conjugate (polyclonal goat anti-mouse IgG alkaline phosphatase
conjugate, diluted 1:30,000 in TBST [Sigma-Aldrich]) and incubated for 1
h at room temperature. Wells were washed twice in 0.1% TBST and once
in TBS, and then color was developed for 1 h using p-nitrophenyl phos-
phate liquid substrate (50 l/well) (Sigma-Aldrich). Absorbance was
measured at 405 nm with a FLUOstar Optima spectrophotometer/fluo-
rimeter/luminometer (BMG LabTech).
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RESULTS
Variation in capsular genotype is confined to a few genes in the
operon. Capsular biosynthesis in S. iniae is under the control of a
21-kb operon containing around 20 genes. The operon has been
fully sequenced (21) and characterized to some degree using site-
directedmutagenesis (18). To determine whether genetic changes
in the capsular operon correlate with infection in vaccinated ani-
mals and virulence, we initially sequenced all genes within the
capsular operon of 10 S. iniae isolates. These strains came from
diverse origins and included strains from documented vaccine
failures (4, 5, 26).
Sequences of the genes from the capsular operon of these 10
isolates resulted in a number of surprising findings (Table 1).
First, the number of synonymous (noncoding) mutations across
the 21-kb operon was incredibly low, compared to coding muta-
tions, which occurred frequently. Coding mutations, resulting in
amino acid changes in the expressed proteins, were restricted to a
limited set of genes within the operon. That is, themutations were
not evenly distributed across all of the 21 kb but were confined to
a limited set of 5 genes, cpsY, cpsD, cpsE, cpsG, and cpsH (Table 1).
Subsequently, we extended our study to an additional 29 iso-
lates and sequenced blocks of genes encompassing these regions
(Table 2).We found that cpsE had the largest diversity (that is, the
largest number of variant sequence types [STs]). However, cpsE
TABLE 2 Nucleotide and amino acid changes associated with differing cps gene sequence types
Gene and position
Nucleotides/amino acids ina:
ST1 ST2 ST3 ST4 ST5b ST6b ST7 ST8
cpsY
535/179 TTC/F TCC/S
cpsD
367/123 CCA/P CTA/L
385/129 TTA/L
475/175 GTG/V TTG/L TTG/L
cpsE
119/40 GAA/E GGA/G GGA/G GGA/G GGA/G GGA/G GGA/G
136/46 TTT/F GTT/V
1426/476 CGT/R CTT/L
1081/361 CAT/H Del C¡ Del C¡
1108/370 TTA/L TAA/stop TAA/stop
1096/366 AAG/K ACG/T
1315/439 GCA/A GTA/V
cpsG
495/165 TTA/L Del TTA/L
498/166 TCA/S Del TCA/S
501/167 AAG/K Del AAG/K
504/167.1 Ins TTA/L
507/167.2 Ins TCA/S
510/167.3 Ins AAG/K
cpsH
669/223 TTA/L TTT/F
a Underlining indicates the changed nucleotide relative to the type strain (ST1). Del, deletion; ins, insertion.
b A single nucleotide deletion leads to a changed amino acid sequence from aa 361 to an early termination at aa 370.
TABLE 1 Sequence types of genes from the capsular operon of 10 isolates of S. iniae separated either geographically or serologicallya
Gene
ST for each strain no. (origin)
QMA0072
(QLD)
QMA0076
(QLD)
QMA0083
(WA)
QMA0140
(USA)
QMA0155
(NSW)
QMA0165
(QLD)
QMA0177
(NT)
QMA0191
(NT)
QMA0188
(ISR)
QMA0186
(ISR)
cpsY 2 2
cpsD 3 3 3 3 3 3 3 3A 2
cpsE 3A 4 3 3 3A 3 3 2 2
cpsG 2 2 3 X X
cpsH 2
a Gene sequences from the type strain (QMA0140) were designated ST1. As coding mutations were discovered, they were allocated a new sequence type number arbitrarily in the
order of discovery. Noncoding mutations are given the ST number of the identical expressed sequence and identified as variants with a letter (e.g., ST3A expresses the same protein
as ST3 but has one or more noncoding single nucleotide polymorphisms [SNPs]). Genes are ST1 if not otherwise indicated. X indicates a deleted gene. Only genes that differ from
the type strain are included in the table. Strain geographic origin abbreviations: QLD, Queensland, Australia; WA, Western Australia; NSW, New South Wales, Australia; NT,
Northern Territory, Australia; USA, United States of America; ISR, Israel.
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was not themost frequentlymodified gene in the operon; variance
in cpsG occurred more frequently in Australian isolates (see Table
S1 in the supplemental material) (5). cpsD was also variable, with
4 different coding sequence types found among the isolates se-
quenced. In contrast, diversity of cpsDwas lower in Australia, with
only two sequence types found. Indeed, ST3 was universal across
all states in Australia, and ST1was identical to the type strain from
dolphins, arising only under high selective pressure in two cases in
New SouthWales and South Australia (see Table S1 in the supple-
mental material; see also the case histories described below). The
cpsY gene also had low variability; all isolates examined carried
ST1, regardless of global geographic origin, with the exception of
the isolates from Northern Territory, Australia, that, without ex-
ception, carried the ST2 cpsY variant (Table 2).
Coding mutations in the capsular operon correlate with au-
togenous vaccine failure. Reoccurrence of infection by S. iniae in
vaccinated fish has been reported previously in Israel (4), and this
appeared to be a result of changes in capsular polysaccharide and
secreted exopolysaccharide (11).We sequenced the complete cap-
sular operon in two postvaccine strains from Israel that had dif-
fering random amplified polymorphic DNA (RAPD) profiles (4)
but that were apparently serologically cross-reactive (4, 11) and
found a single coding mutation in cpsD (Table 1) resulting in a
change from proline to leucine at amino acid (aa) position 123.
Northern Territory, Australia. In April 2005, streptococcosis
emerged as a cause of high mortalities in farmed barramundi in
Port Hurd, Northern Territory (NT), Australia. In July 2005, a
cohort of fingerlings was vaccinated with an autogenous vaccine
prepared from the isolate obtained from the index case and des-
ignated strainQMA0191 in the UQ strain collection (Table 3) and
introduced onto the site. Further cases of clinical streptococcosis
were recorded in the fish at Port Hurd in July, August, and Sep-
tember as well as isolated from brain and kidney in subclinically
infected fish. All these cases were in nonvaccinated fish and are
represented by the strain numbers QMA0142, QMA0150, and
QMA0153 (Table 3). In July 2006, an outbreak of clinical strepto-
coccosis occurred in multiple cohorts of fish across the farm, in-
cluding fish vaccinated with the autogenous vaccine containing
strain QMA0191. An isolate taken at this time was also deposited
in the UQ collection and designated QMA0177.
Analysis of the capsular genotypes of the strains recovered
from unvaccinated fish during 2005 indicated a consistent molec-
ular serotype identical to that of the strain (QMA0191) used to
produce the autogenous vaccine and explains the efficacy of the
vaccine (Table 3). When disease arose across the site in July 2006,
more than 6 months after vaccination, mortality resulted from
strains with a coding change in cpsG, a 6-amino-acid (2 LSK
repeat) insert.
South Australia. Vaccination of barramundi in a tank-based
aquaculture facility in South Australia (SA) commenced in late
2004 using an autogenous vaccine prepared from an isolate from
an outbreak in December 1999 (QMA0160). A subsequent out-
break resulted from a new strain in May 2006 (QMA0243) and
again in October 2008 (QMA0244, QMA0255), continuing
through the Southern-hemisphere summer to March 2009
(QMA0246 to QMA248), with all isolates exhibiting a shift in
amino acid composition in the cpsG (ST1 and ST2) genes (Table
3). A new autogenous vaccine incorporating both strain types was
used to vaccinate new stock in March to April 2009. In May 2009,
low-level mortality was detected in vaccinated stock, but symp-
toms were atypical; barramundi developed spinal fractures. In
some vaccinated fish, these spinal fractures were colonized by
Gram-positive cocci, perpetuating spinal inflammation (Fig. 1).
The brain and head-kidney (pronephros) of nine fish were sam-
TABLE 3 Case histories of strain isolation and vaccination in three farms, a sea farm in Northern Territory and recirculating aquaculture farms in
South Australia and New South Walesa
Location Strain
ST of:
Date of isolation
(mo/yr) Dates used in vaccinescpsD cpsE cpsG
Northern Territory QMA0191 (v) 3 3 1 04/2005 2005-2006
QMA0142 3 3 1 07/2005
QMA0150 3 3 1 08/2005
QMA0153 3 3 1 09/2005
QMA0177 3 3 3 07/2006
South Australia QMA0160 (v) 3 3 1 12/1999 2004–2009
QMA0159 3 3 2 03/2006
QMA0243 3 3 2 05/2006
QMA0244, QMA0245 3 3 2 10/2008
QMA0246, QMA0247, QMA0248 3 3 2 03/2009 March/April 2009 divalent
with QMA0160
QMA0249 1 5* X 05/2009
New South Wales QMA0155 (v) 3 3 2 12/2005 Early 2006 monovalent
QMA0220 3 3 2 08/2006 2007-2008
QMA0250 3 3 2 11/2007 January 2008
QMA0251, QMA0252 3 3 2 06/2008 July 2008 divalent
QMA0233 1 5A* X 11/2008
QMA0253, QMA0254 1 5A* X 01/2009 March 2009 divalent
QMA0236 1 5A* X 03/2009
a Numbers indicate sequence types of indicated cps genes. X indicates a gene deletion. All other genes in the cps operon were identical among strains in the same table unless
otherwise indicated. *, strain had genes cpsF-cpsM deleted; (v), strain used in initial autogenous vaccine;, isolate used in subsequent vaccinations.
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pled for bacteria, but no S. iniae was recovered, nor was S. iniae
observed in the kidney during histology. S. iniae was observed in,
and recovered from, only the bone lesions and the resulting exu-
date (Fig. 1). The isolates that caused this unusual pathology were
found to have a frameshift mutation (single nucleotide deletion at
nucleotide [nt] position 1081) in the cpsE gene that resulted in an
early stop codon at amino acid 370, resulting in a severely trun-
cated protein. Moreover, all of the capsular operon genes from
cpsF-cpsM were deleted in these isolates (Table 3).
New South Wales, Australia. A similar but separate case oc-
curred at a recirculating aquaculture farm in NSW: barramundi
were vaccinated with autogenous bacterins prepared from isolates
QMA0155/QMA0220 that caused an outbreak that ran from late
2005 into early 2006. In November 2008, an outbreak occurred in
vaccinated stock. As with the SA case, mortalities were low and
associated with spine deformities in which streptococci were able
to be detected in histology and from which S. iniae was subse-
quently isolated in culture. These isolates had a similar frameshift
mutation in cpsE, coupled with deletion of cpsF-cpsM (Table 3).
Changes in genotype associatedwith vaccine failure are phe-
notypically and antigenically relevant. In the vaccine failure case
in Northern Territory, Australia, a single mutation was found in
the cpsG gene (from ST1 to ST3). A buoyant density assay was
performed to assess any phenotypic variation between the cps
genes. Buoyant density was different in the two isolates, with iso-
lateQMA0177 traveling further through a continuous Percoll gra-
dient than strain QMA0191. This occurred with multiple inde-
pendently prepared cell suspensions through Percoll gradients
prepared at two dilutions. In the case of the SA and NSW cases
with truncated cpsE and major deletions in the operon, the differ-
ences in buoyant density were more pronounced, with the mu-
tated isolates QMA0253, QMA0236, and QMA0249 migrating
completely through the continuous gradient when prepared using
diluted Percoll (Fig. 2).
To investigate whether the changes seen in the capsular operon
that coincided with reinfection of vaccinated fish were antigenically
relevant, antibodies were raised in barramundi against the two iso-
lates from the index case of reinfection in NT. Antibodies raised
against QMA0191 were poorly cross-reactive with QMA0177 by a
whole-cell ELISA (Fig. 3A). Similarly, antiserum raised against
QMA0177 was poorly cross-reactive with QMA0191. In the case of
the strains fromNSW, antisera raised in barramundi against the ini-
tial vaccine isolate QMA0155 (same CPS sequence type as the subse-
quent vaccine strains QMA250 to QMA252) cross-reacted strongly
with strain QMA0236, which occurred in vaccinated fish (Fig. 3B).
When fishwere vaccinatedwithQMA0236, a relatively low antibody
response was detected in general, even against the same strain in a
whole-cell ELISA, although it was higher than that for the negative-
control serum. Although the response was low, it was significantly
higher in a whole-cell ELISA against the homologous strain than
against QMA0155 (Fig. 3B) (P 0.05).
FIG 1 Histopathology of spinal inflammation in infected barramundi. (A) L. calcarifer sagittal spinal vertebral section showing normal structure of central
vertebral spongy bone trabeculae, indicated by T, and endplate, indicated by E, at 40 magnification (hematoxylin and eosin [H&E]). (B) L. calcarifer spinal
sagittal section at the point of collapse, indicated by C, of the intervertebral disc space due to inflammatory infiltrate and fracture of the vertebra, indicated by F,
at40 magnification (H&E). (C) L. calcarifer spinal sagittal section showing multiple colonies of Gram-positive cocci. Arrows indicate inflamed and necrotic
tissue exudate, indicated byN, at the site of spinal fracture at200magnification (H&E). (D) L. calcarifer spinal sagittal section showing a severe intraspinal canal
infiltrationwith inflammatory cells, caseous necrotic foci, indicated byN, containing colonies of phagocytosed coccoid bacteria. Inflammatory exudate is in close
proximity to the spinal cord, indicated by S, at 40 magnification (H&E). (E) Gram stain of an L. calcarifer sagittal spinal section showing colonies of
Gram-positive coccoid and chain-forming bacteria in close associationwith the vertebral bony surfaces at1,000magnification. (F)Gram stain of an L. calcarifer
spinal vertebral inflammatory exudate showing multiple Gram-positive coccoid bacteria. Note the potentially phagocytosed bacteria in cells (arrows), but there
are also free bacteria in the exudate, at1,000 magnification.
FIG 2 Percoll buoyant density assay for NT (QMA0177, QMA0191), SA
(QMA0160, QMA0243, QMA0249), and NSW (QMA0155, QMA0220,
QMA0236, QMA0253) isolates.
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DISCUSSION
Vaccination of finfish against bacterial pathogens has proven ex-
tremely effective at preventing mass mortality in farmed animals
(29). However, it is this very efficacy that places a high selective
pressure on pathogens, and this may lead to dominance by new
serotypes less well recognized by the resultant specific immune
response to the original vaccine. In the present study, we investi-
gated genetic changes in S. iniae, a fish pathogen with a track
record of new serotype emergence in vaccinated animals (4). We
found mutations in the capsular operon that coincided with in-
fection in previously vaccinated stocks. These genetic changes
likely lead to changes in polysaccharide biosynthesis (6, 11). In-
triguingly, changes were restricted to a limited suite of genes
within the 20-gene operon. Firstly, two sequence types were
found in cpsY. Of 39 isolate sequences, only strains fromNorthern
Territory, Australia, contained the cpsY ST2 variant, with all other
isolates being identical to the type strain. It is intriguing that a new
sequence type should be found only inNT, especially whenmove-
ments of fingerlings interstate are common. This suggests that S.
iniae infections arose locally in the fish after theywere shipped and
that the bacterium was not cotransported with the fingerlings
from the Darwin hatchery. cpsY ST2 would currently appear to be
a robust diagnostic indicator for NT origin of the strain. cpsY is a
transcriptional regulator that has an important role in intracellu-
lar survival in neutrophils and is also essential for successful dis-
semination to the brain (2, 3). The functional role of themutation
in the present case is unknown, but isolates were recovered from
the brain in both outbreaks.
cpsA through cpsC were always identical to the type strain, re-
gardless of the country of origin. In S. pneumoniae, cpsD is a self-
phosphorylating tyrosine kinase, acting with cpsB and cpsC to reg-
ulate activity of cpsE (22–25). cpsD was found to vary in S. iniae
and was the only coding mutation in the cps operon that was
different between the two postvaccine isolates from the Israeli case
of vaccine failure, with a switch in the amino acid at position 123
from proline to leucine. While the effect of this mutation at the
functional level remains to be determined, a proline-leucine
switch at this position will substantially change the shape of the
protein, removing a bend at this residue. The Israeli team reported
that these two isolates (named KPF177 [QMA0188] and KPF404
[QMA0186]) were serologically similar when tested with rabbit
antisera using Ouchterlony immunodiffusion, but they differ in
RAPD profiles (4). Each of these strains has been used in autoge-
nous vaccines, and a novel serotypewhich differed in EPS produc-
tion arose (11). It would be interesting to investigate the CPS
operon of the newly emerged strain to determine whether coding
mutations in the capsular biosynthesis machinery that led to in-
creased polysaccharide overexpression or failure to anchor the
membrane have arisen. In Australia, a coding mutation in cpsD
was never found as the sole mutation in the cps operon, with most
isolates analyzed having the ST3 cpsD sequence type. The only
other cpsD variant found in Australia isolates was cpsD ST1, and
this was found only in association with a frameshift mutation in
cpsE. Once again, this cpsD mutation (ST3 to ST1) involved the
proline-leucine switch at aa 123, derived from an identical single
nucleotide mutation. In Australia, however, the proline-leucine
switchwas also accompanied by a valine-leucine substitution at aa
175. The effects of cpsDmutations will be difficult to interpret in
Australian isolates due to the universal accompaniment of the
change with a frameshift in cpsE. In S. iniae, cpsE encodes a UDP-
glucose-dependent glycosyl transferase that initiates synthesis and
export of the capsular polymer. There was more diversity of this
gene than of any of the other cps genes, with 6 different sequence
types found among the S. iniae isolates recovered in Australia and
8 in total among the 39 isolates analyzed. It is likely thatmutations
in this gene change the amount of capsular polysaccharide pro-
duced, and this can have profound effects on the tissue distribu-
tion of the organism during disease (18). Indeed, the frameshift
mutations that resulted in early termination of the cpsE gene that
occurred in strains infecting vaccinated fish in NSW and SA sub-
stantially increased the buoyant density, suggesting reduced/elim-
inated capsular polysaccharide production. This was associated
with lower mortality and completely transformed pathology and
symptoms.While these mutations often cooccurred with deletion
of genes cpsF through cpsM (isolates QMA0233 to QMA0236; iso-
late QMA0249), it appears that the frameshift mutation in cpsE
alone is sufficient to cause the phenotypic changes, as isolate
QMA0158 (frameshift in cpsE, but remainder of the operon in-
tact) exhibited an increase in buoyant density similar to that of the
strains carrying the deletion of cpsF-cpsM. Deletion of cpsF-cpsM
has been reported previously in a “commensal” strain of S. iniae
(18). Our research suggests that these strains are not commensal,
as they still cause pathology and mortality in a farm situation, but
are somewhat attenuated (data not shown). This association with
spinal fractures in barramundi is interesting, as human spinal os-
teomyelitis caused by Streptococcus dysgalactiae subsp. equisimilis
has been reported (14). The structure of teleost fish bone is with-
out a marrow cavity and Haversian system, which means that
osteomyelitis cannot occur. However, inflammation can develop
in avascular tissue by extension from the adjacent periosteal ves-
sels and generally takes the form of rarefaction (demineralization)
rather than frank necrosis. Teleost bone usually cannot be immo-
FIG 3 Antibody cross-reactivity by a whole-cell ELISA for selected isolates from the index case inNT (QMA0177, QMA0191) (A) and theNSWcase (QMA0155,
QMA0236) (B).
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bilized in a fracture situation and thus will heal in a deformed
fashion, as observed in the cases reported here (data not shown).
cpsG is a putative UDP-glucose 4 epimerase that converts
UDP-glucose to UDP-galactose. Three variants of cpsG, involving
an insertion or deletion of three amino acids, LSK, at aa positions
165, 166, and 167 in the ST1 type strain, were found. In ST2, these
three amino acids were deleted, while in ST3, they were repeated,
resulting in a protein that was three amino acids longer than the
type strain. The phenotypic effects of thesemutations remain to be
determined, but mutations in this gene that alter enzyme effi-
ciency may change the rate of conversion and thus change the
ratio of glucose/galactose in the final capsular polymer, with re-
sulting effects on surface epitopes.Mutation from cpsG ST1 to ST3
was the only change in the index case of vaccine failure in Austra-
lia. This involves a 3-aa LSK repeat insertion in ST3 compared to
ST1. How this may affect function is yet to be elucidated, but the
two isolates involved were serologically different, as determined
by an ELISA using fish antiserum. Moreover, there was a small
change in the buoyant density of the cells, suggesting a change in
CPS structure. Future work will focus on expressing these variants
as recombinant proteins and measuring their epimerase activity.
This, coupled with liquid chromatography-mass spectrometry
(LC-MS) analysis of CPS from these two isolates, may elucidate
how these mutations translate into antigenic variation. cpsG was
deleted in a number of isolates, including the Israeli and Thai
isolates, suggesting that it may not be essential for cps biosynthesis
but may play an important role in the final molecular shape of the
polysaccharides.
No cases of reinfected vaccinated fish have yet been associated
with changes in cpsH, although two variants were found among
the Australian strains. cpsH is a putative repeat unit polymerase,
and changes in efficacymay change polymer length and, therefore,
the final structure and antigenic nature of the capsule.
When disease arises in enclosed tank-based aquaculture sys-
tems, theoretically, best practice would be to close down the sys-
tem, disinfect it completely, dismantle and clean pipework,
pumps, and filtration, and then restart with clean stock. In prac-
tice, this is not possible, as multiple size classes are generally kept
within the same system to allow a continual supply of table-sized
fish for customers. Thus, outbreaks of S. iniae may be controlled
with careful antibiotic treatment, and vaccinated stock may be
reintroduced into the system. However, this means that the reser-
voir of infection is never really eradicated, providing ample op-
portunity for reinfection should immunity become compro-
mised. In the closed systems in NSW and SA, careful use of
autogenous vaccines initially controlled disease. In the latter pe-
riod of the study, divalent vaccineswere formulated after sequence
typing to include the cps STs from the history of infection on the
farm. It is intriguing that streptococcosis once again occurred in
these farms in 2008/2009 but with substantially changed pathol-
ogy and greatly reduced mortality among the infected fish. More-
over, strains from both sites were typed and found to carry the
frameshiftmutation in cpsE (cpsE ST5/5A) and the deletion of cpsF
through cpsM, although fingerlings came from different sources.
The development of these very similar cases suggests the possibil-
ity of a common origin for the isolate. However, a silent mutation
after the early termination signal in cpsE was found in the NSW
isolates (hence cpsE ST5A), hinting that the SA case andNSW case
may have arisen independently. Interestingly, the unusual trunca-
tion of cpsEwas also found in a strain isolated several years earlier
in Thailand. Whether this type has been introduced or whether it
is a natural adaptation to host-specific immunity that occurs in-
dependently is unknown. It is likely that such a serious mutation
in the capsular operon results in complete cessation of the capsu-
lar biosynthesis machinery and therefore creates a capsule-defi-
cient mutant, as evidenced by our buoyant density results. This
may explain the unusual pathology and very low mortality rate in
the fish, as a capsule-deficient strain, while not recognized by anti-
CPS antibodies, would be highly susceptible to phagocytic attack
and may seek refuge in the bone of already-compromised fish.
When antibodies raised against QMA0155, the initial sequence
type found on this farm, were used in a whole-cell ELISA, they
cross-reacted with strain QMA0236 but not vice versa. This may
reflect a lack of CPS in QMA0236; while whole-cell bacterins pre-
pared with QMA0155 would result in anti-cps antibodies along
with a range of antibodies against other cell components, includ-
ing integral membrane proteins, which are highly conserved
among S. iniae (6) and would be exposed to antibody binding on
CPS-deficient QMA0236, the converse would not be true. Integral
membrane proteins of QMA0155would likely be coated with CPS
and unavailable for antibody binding in a whole-cell ELISA.
In summary, coding mutations in the capsular operon of S.
iniae appear to correlate with reinfection of previously vaccinated
fish. These mutations are restricted to a few key genes in the20-
gene operon. Twokey questions remain to be answered. First, how
do the genetic changes in the capsular operon, translated changes
in the protein machinery for polysaccharide biosynthesis and ex-
port, actually lead to phenotypic and antigenic changes on the
surface of the cell? Second, is vaccination driving mutation of
highly mutable loci within a single strain type extant on a farm at
a particular time, or is vaccinationmerely selecting the fittest vari-
ant from a pool of varied serotypes that are present among the
population? The high ratio of nonsynonymous to synonymous
mutations (dN/dS) among the genes of the CPS operon suggests
that these changes are being driven under strong selective pres-
sure. Further work aimed at answering these questions is ongoing.
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